Indication

Hyperreninemia

1 clinical trial

1 product

1 drug

Clinical trial

Biomarker-guided Implementation of Angiotensin-II (AT-II) to Reduce the Occurrence of Kidney Damage After Cardiac Surgery

Status: Completed, Estimated PCD: 2022-12-19

Product

Drug